Search Results - "Bang, S.M."

Risk Factors Associated With Locoregional Failure After Surgical Resection in Patients With Resectable Pancreatic Cancer by Kim, H.J, Lee, W.J, Kang, C.M, Hwang, H.K, Bang, S.M, Song, S.Y, Seong, J

Get full text

Long Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis by Senzolo, M, Riva, N, Dentali, F, Bang, S.M, Martinelli, I, Schulman, S, Alatri, A, Beyer-Westendorf, J, Di Minno, M.N.D, Rodriguez, K, Sartori, M.T, Ageno, W

Get full text

O-019 Head-to-head comparison of 5-azacitidine versus decitabine for the treatment of myelodysplastic syndrome by Kim, I, Lee, Y.G, Yoon, S.S, Park, S, Cheong, J.W, Min, Y.H, Bang, S.M, Kim, C.S, Park, Y, Mun, Y.C, Seong, C.M, Park, J, Lee, J.H, Lee, H.G, Kim, Y.K, Kim, H.J

Get full text

P-286 Azacitidine pretreatment followed by non-myeloablative SCT in patients with high-risk myelodysplastic syndrome: Prospective, open label, multicenter, phase II trial by Kim, H, Jae-Sook, A, Kim, Y, Min, Y.H, Kim, J.S, Jang, J.H, Jung, C.W, Kim, I.H, Yoon, H.J, Lee, H.G, Sohn, S.K, Moon, J.H, Kim, Y.J, Won, J.H, Bang, S.M, Chung, J.S, Mun, Y.C

Get full text

6573 The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer by Lee, K.W, Bang, S.M, Kim, Y.J, Kim, J.H, Park, D.J, Kim, H.H, Oh, D, Lee, J.S

Get full text

Adjuvant Radiotherapy and Chemotherapy Offer a Recurrence and Survival Benefit in Patients with Resected Perihilar Cholangiocarcinoma by Im, J.H., Choi, G.H., Lee, W.J., Han, D.H., Park, S.W., Bang, S.M., Choi, H.J., Seong, J.

Get full text

PS1471 MYELOPROLIFERATIVE NEOPLASMS IN KOREAN CHILDREN AND YOUNG ADULTS by Choi, H.S., Hong, J., Lee, J.H., Bang, S.M.

“…Background: Myeloproliferative neoplasms (MPNs) are a rare, heterogeneous group of clonal hematopoietic stem cell disorders, characterized by aberrant…”
Get full text

PS064 - Long Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis by Senzolo, M., Riva, N., Dentali, F., Bang, S.M., Martinelli, I., Schulman, S., Alatri, A., Beyer-Westendorf, J., Di Minno, M.N.D., Rodriguez, K., Sartori, M.T., Ageno, W.

Get full text

The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer by LEE, K. W., BANG, S. M., KIM, S., LEE, H. J., SHIN, D. Y., KOH, Y., LEE, Y. G., CHA, Y., KIM, Y. J., KIM, J. H., PARK, D. J., KIM, H. H., OH, D., LEE, J. S.

“…Background: Data on venous thromboembolism (VTE) in gastric cancer (GC) are very scarce. Objective: To investigate the incidence, risk factors and prognostic…”
Get full text

Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer by Chang, H.J., Lee, K.-W., Kim, J.H., Bang, S.M., Kim, Y.J., Kim, D.W., Kang, S.B., Lee, J.S.

“…This study was conducted to analyze the feasibility of adjuvant capecitabine therapy using a tailored-dose escalation strategy in elderly patients with colon…”
Get full text

Clinical outcomes of high-dose chemotherapy using mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation in chemosensitive relapsed or primary refractory aggressive non-Hodgkin's lymphoma patients by Kim, J.W, Kim, B.S, Bang, S.M, Kim, J.S, Lee, S.T, Kim, I, Yoon, S.S, Lee, J.S, Han, K.S, Park, S, Kim, B.K

“…Chemosensitive relapsed or primary refractory aggressive non-Hodgkin's lymphoma (NHL) patients (pts) could benefit from high-dose chemotherapy (HDC) followed…”
Get full text

The Intention To Treat Analysis of the Different Post Remission Therapy Modalities in AML Patients with the “Intermediate Risk Group (IPG)” Based on Cytogenetics by Mun, Yeung-Chul, Lee, S.M., Park, S.H., Cho, E.K., Lee, J.H., Jo, D.Y., Kim, I.H., Yoon, S.S., Park, S.Y., Bang, S.M., Min, Y.J., Seo, J.J., Lee, M.H., Kim, C.S., Joo, Y.D., Chung, S.Y., Oh, D.Y., Zang, D.Y., Lee, K.H., Hyun, M.S., Song, H.S., Kim, H.S., Kwon, H.C., Kim, H.J., Park, Y.H., Ahn, M.J., Ahn, J.S., Park, K.T., Bae, S.H., Ryoo, H.M., Yoon, H.J., Kim, B.S., Ghim, Thad, Seong, Chu-Myong

“…The results of cytogenetics are one of the most important prognostic factors in the prognosis of AML. Three different post remission therapies were given with…”
Get full text

Interim Anaiysis of Intention To Treat Analysis, “Multicenter AML-2000 Trial” Based on Cytogenetics Risk Factors by Mun, Yeung-Chul, Lee, S.M., Bang, S.M., Park, S.H., Cho, E.K., Lee, J.H., Jo, D.Y., Kim, S.Y., Kim, I.H., Yoon, S.S., Park, S.Y., Kim, B.K., Min, Y.J., Seo, J.J., Ghim, Thad, Lee, M.H., Kim, C.S., Joo, Y.D., Chung, S.Y., Oh, D.Y., Ahn, J.S., Zang, D.Y., Lee, K.H., Kim, M.K., Hyun, M.S., Song, H.S., Kim, H.S., Kwon, H.C., Kim, H.J., Park, K.T., Bae, S.H., Ryoo, H.M., Ahn, M.J., Yoon, H.J., Kim, B.S., Park, Y.H., Seong, C.M.

“…The result of cytogenetics is one of the most important prognostic factors on the prognosis of AML. HDAC, auto PBPCT and allogeneic BMT after 1 or 2 times of…”
Get full text

Changes in hand function in the aging adult as determined by the Jebsen Test of Hand Function by Hackel, M E, Wolfe, G A, Bang, S M, Canfield, J S

“…The Jebsen Test of Hand Function is used to assess a broad range of hand functions required for activities of daily living. The time needed to complete a…”
Get more information